木瓜直播

Healthcare workers cited as a barrier to getting treatment for mental health issues, according to a national internet panel survey. (Morbidity and Mortality Weekly Report)

Iclepertin, an investigational glycine transporter 1 inhibitor, missed both primary and key secondary endpoints for in the 6-month phase III CONNEX trial, said developer Boehringer Ingelheim.

Women who were receiving (OUD) were less likely to be prescribed birth control compared with those who were not, an analysis of claims data showed. (JAMA Internal Medicine)

Researchers identified that increase the risk for bipolar disorder. (Nature)

National data confirm for children. (American Journal of Psychiatry)

Girls who had their first period before the age of 11.5 years had 47% higher odds for , according to national survey data. (Pediatric Research)

Could the largest market for the new schizophrenia drug be in Alzheimer's disease psychosis, agitation, and cognition? Bristol Myers Squibb executives seem to think so. (CNBC)

Lykos Therapeutics, developer of the once-rejected drug midomafetamine (MDMA) capsules for post-traumatic stress disorder, said it had last week and continues to "chart a path forward for an independent third-party review" of phase III trial data.

No surprise here: chronic stress was 10 years later, a population-based cohort study of German students found. (Scientific Reports)

Here's how manages inmates with OUD. (New York Times)

A meta-analysis found that among young people may help in the short-term. (JAMA Network Open)

Comment